Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr Virus

To establish a persistent latent infection, Epstein-Barr virus (EBV) faces a challenge in that the virus-infected host cell must transit through the germinal centre reaction. This is a site of B cell differentiation where antibody responses are optimised, and the selection criteria for B cells are s...

Full description

Saved in:
Bibliographic Details
Main Authors: Lindsay C. Spender, Gareth J. Inman
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2011/829525
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553933537542144
author Lindsay C. Spender
Gareth J. Inman
author_facet Lindsay C. Spender
Gareth J. Inman
author_sort Lindsay C. Spender
collection DOAJ
description To establish a persistent latent infection, Epstein-Barr virus (EBV) faces a challenge in that the virus-infected host cell must transit through the germinal centre reaction. This is a site of B cell differentiation where antibody responses are optimised, and the selection criteria for B cells are stringent. The germinal centre environment is harsh, and the vast majority of B cells here die by apoptosis. Only cells receiving adequate survival signals will differentiate fully to be released into the periphery as long-term memory B cells (the site of persistence). In this review, we detail the apoptotic pathways potentially encountered by EBV-infected B cells during the process of infection, and we describe the functions of those EBV-regulated cellular and viral genes that help promote survival of the host B cell.
format Article
id doaj-art-2d82a477aca44c288c441c360a3d4dd3
institution Kabale University
issn 1687-9104
1687-9112
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Advances in Hematology
spelling doaj-art-2d82a477aca44c288c441c360a3d4dd32025-02-03T05:52:48ZengWileyAdvances in Hematology1687-91041687-91122011-01-01201110.1155/2011/829525829525Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr VirusLindsay C. Spender0Gareth J. Inman1Division of Cancer Research, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UKDivision of Cancer Research, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, UKTo establish a persistent latent infection, Epstein-Barr virus (EBV) faces a challenge in that the virus-infected host cell must transit through the germinal centre reaction. This is a site of B cell differentiation where antibody responses are optimised, and the selection criteria for B cells are stringent. The germinal centre environment is harsh, and the vast majority of B cells here die by apoptosis. Only cells receiving adequate survival signals will differentiate fully to be released into the periphery as long-term memory B cells (the site of persistence). In this review, we detail the apoptotic pathways potentially encountered by EBV-infected B cells during the process of infection, and we describe the functions of those EBV-regulated cellular and viral genes that help promote survival of the host B cell.http://dx.doi.org/10.1155/2011/829525
spellingShingle Lindsay C. Spender
Gareth J. Inman
Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr Virus
Advances in Hematology
title Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr Virus
title_full Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr Virus
title_fullStr Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr Virus
title_full_unstemmed Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr Virus
title_short Inhibition of Germinal Centre Apoptotic Programmes by Epstein-Barr Virus
title_sort inhibition of germinal centre apoptotic programmes by epstein barr virus
url http://dx.doi.org/10.1155/2011/829525
work_keys_str_mv AT lindsaycspender inhibitionofgerminalcentreapoptoticprogrammesbyepsteinbarrvirus
AT garethjinman inhibitionofgerminalcentreapoptoticprogrammesbyepsteinbarrvirus